SCHEMBL6597472

SCHEMBL6597472

Cc1ccc(Nc2nccc(-c3c(C)c(C#N)n(-n4c(C)c(-c5ccnc(Nc6ccc(N(C)C)cc6)n5)c(C)c4C#N)c3C)n2)cc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 13/20 0.49
CDK4 P11802 10/20 0.49
CCNE1 P24864 2/20 0.43
AURKA O14965 2/20 0.43
AURKB Q96GD4 2/20 0.43
CDK1 P06493 1/20 0.43
CDK7 P50613 1/20 0.43
CDK9 P50750 1/20 0.43
EIF2AK2 P19525 1/20 0.40
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39
CAMK2D Q13557 1/20 0.38
GSK3B P49841 3/20 0.38
MAP4K4 O95819 1/20 0.37
PIM1 P11309 1/20 0.37
MAPK8 P45983 1/20 0.37
HIPK2 Q9H2X6 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
IRAK4 Q9NWZ3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6597467 0.82 CDK2 (0.73) CDK2CDK4CCNE1AURKAAURKB
SCHEMBL4613643 0.82 CDK2 (0.50) CDK2CDK4CCNE1AURKAAURKB
SCHEMBL6600528 0.81 CDK2 (0.50) CDK2CDK4CCNE1AURKAAURKB
SCHEMBL6600211 0.81 CDK4 (0.58) CDK2CDK4AURKBEIF2AK2GSK3B
SCHEMBL6599785 0.76 CDK2 (0.52) CDK2CDK4CDK9EIF2AK2GSK3B
SCHEMBL6599378 0.76 CDK4 (0.45) CDK2CDK4AURKBEIF2AK2GSK3B
SCHEMBL6600190 0.76 CDK4 (0.58) CDK2CDK4AURKBGSK3B
SCHEMBL6601086 0.74 CDK2 (0.58) CDK2CDK4AURKBCDK1CDK7
SCHEMBL4613825 0.73 CDK2 (0.85) CDK2CDK4AURKAAURKBEIF2AK2
SCHEMBL6605375 0.73 CDK2 (0.62) CDK2CDK4CCNE1AURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373253-A1 INHIBITORS OF CYCLIN DEPENDENT KINASES AS ANTI-CANCER AGENT Cyclacel Limited (GB) 2004-01-02 EP claimed
WO-2002079193-A1 INHIBITORS OF CYCLIN DEPENDENT KINASES AS ANTI-CANCER AGENT CYCLACEL LIMITED (GB) 2002-10-10 WO claimed
EP-1373253-A1 INHIBITORS OF CYCLIN DEPENDENT KINASES AS ANTI-CANCER AGENT Cyclacel Limited (GB) 2004-01-02 EP disclosed
WO-2002079193-A1 INHIBITORS OF CYCLIN DEPENDENT KINASES AS ANTI-CANCER AGENT CYCLACEL LIMITED (GB) 2002-10-10 WO disclosed